Akebia Therapeutics Inc
(NAS:AKBA)
$
1.52
-0.03 (-1.94%)
Market Cap: 319.64 Mil
Enterprise Value: 333.85 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 44/100 Akebia Therapeutics Inc (AKBA) Transcripts
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Q3 2023 Akebia Therapeutics Inc Earnings Call TranscriptNov 08, 2023$0.96 (-11.93%)Earnings
- Q2 2023 Akebia Therapeutics Inc Earnings Call TranscriptAug 25, 2023$1.15 (-8.00%)Earnings
- Akebia Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Akebia Therapeutics Inc To Discuss The Response To The FDRR TranscriptMay 30, 2023
- Q1 2023 Akebia Therapeutics Inc Earnings Call TranscriptMay 08, 2023$1.06 (-2.75%)Earnings
- Akebia Therapeutics Inc to Host Stockholder Information Session TranscriptApr 21, 2023
- Q4 2022 Akebia Therapeutics Inc Earnings Call TranscriptMar 09, 2023$0.8007 (-22.26%)Earnings
- Q3 2022 Akebia Therapeutics Inc Earnings Call TranscriptNov 03, 2022$0.2851 (+7.34%)Earnings
- Q2 2022 Akebia Therapeutics Inc Earnings Call TranscriptAug 04, 2022$0.41 (+4.99%)Earnings
- Q1 2022 Akebia Therapeutics Inc Earnings Call TranscriptMay 09, 2022$0.3454 (-10.26%)Earnings
- Akebia Therapeutics Inc Corporate Call TranscriptMar 30, 2022
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Akebia Therapeutics Inc Earnings Call TranscriptNov 09, 2021$2.86 (-0.35%)Earnings
- Akebia Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- Akebia Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 09, 2021
- Q2 2021 Akebia Therapeutics Inc Earnings Call TranscriptAug 05, 2021$2.87 (+15.73%)Earnings
- Akebia Therapeutics Inc Annual Shareholders Meeting TranscriptJun 02, 2021
- Q1 2021 Akebia Therapeutics Inc Earnings Call TranscriptMay 10, 2021$2.9 (-7.05%)Earnings
- Q4 2020 Akebia Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$3.47 (-18.93%)Earnings
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Akebia Therapeutics Inc Earnings Call TranscriptNov 05, 2020$2.49 (-3.11%)Earnings
- Akebia to Present Global Phase 3 Vadadustat Data at American Society of Nephrology Kidney Week 2020 Reimagined TranscriptOct 23, 2020
- Akebia Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 15, 2020
- Akebia Therapeutics Inc Conference Call and Live Webcast to Discuss the PRO(2)TECT Data TranscriptSep 03, 2020
- Akebia Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 02, 2020
- Q1 2020 Akebia Therapeutics Inc Earnings Call TranscriptMay 05, 2020$11.95 (+37.99%)Earnings
- Q4 2019 Akebia Therapeutics Inc Earnings Call TranscriptMar 10, 2020$7.43 (-7.70%)Earnings
- Akebia Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- Q3 2019 Akebia Therapeutics Inc Earnings Call TranscriptNov 12, 2019$3.33 (-9.02%)Earnings
- Akebia Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Akebia Therapeutics Inc Earnings Call TranscriptAug 08, 2019$4.17 (+13.93%)Earnings
- Q1 2019 Akebia Therapeutics Inc Earnings Call TranscriptMay 09, 2019$5.92 (+0.51%)Earnings
- Q4 2018 Akebia Therapeutics Inc Earnings Call TranscriptMar 18, 2019Earnings
- 1